Study Finds on MSN
Blood Test Accurately Detects 81% Of Earliest Lung Cancers By Looking For Molecular Chaos
In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
University of Queensland researchers who mapped cancer cell "neighborhoods" in the most common type of lung cancer have found ...
FOX 13 Tampa Bay on MSN
Moffitt researchers develop algorithm to predict cancer cell evolution
Researchers at Moffitt Cancer Center have developed a new tool to predict how cancer cells evolve. By focusing on chromosome ...
Hosted on MSN
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer
Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and ...
Artificial intelligence-powered spatial analysis of tumor microenvironment in non-small cell lung cancer patients who acquired resistance after EGFR tyrosine kinase inhibitors. This is an ASCO Meeting ...
Response and long-term survival in stage IV lung adenocarcinoma as predicted by serial 3-D explant analyses with molecular correlates: Tumor biology as evolutionary biology. This is an ASCO Meeting ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung, the Company’s commercially available test for early-stage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results